The Differentiation of Chronic Obstructive Pulmonary Disease from Asthma: a Review of Current Diagnostic and Treatment Recommendations

Overview

Journal Open Nurs J

Publisher Bentham Open

Specialty Nursing

Date 2013 Jun 27

PMID 23802028

Citations 1

Authors

Pamela Spencer

Bruce Krieger

Affiliations

Soon will be listed here.

Abstract

Aim: Global and regional data have shown that chronic airway diseases such as chronic obstructive pulmonary disease (COPD) and asthma are increasing in incidence and prevalence, with detrimental consequences to healthcare resources and the quality of life of patients. A firm diagnosis of COPD or asthma is important because the natural history, treatment, and outcomes differ between the two respiratory diseases. The aim of this review is to provide nurse practitioners (NPs) with the requisite facts to understand and improve the diagnosis and treatment of affected individuals.

Methods: Articles on the differential diagnosis, treatment, and management of COPD and asthma published in peer-reviewed journals were retrieved from PubMed. Evidence-based respiratory guidelines, World Health Organization disease-related data, and US prescribing information for different respiratory medications served as additional data sources.

Conclusions: NPs, along with other primary care professionals, form the frontline in diagnosing, treating, and managing COPD and asthma. Differentiating COPD from asthma has prognostic as well as significant therapeutic implications. Since NPs play a key role in diagnosing and managing patients with COPD and asthma, those with a comprehensive understanding of the diagnostic and therapeutic differences between the two diseases can help to lower the risks of exacerbations and hospitalizations, and improve the quality of life of these patients.

Citing Articles

Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection.

Lugade A, Bogner P, Thatcher T, Sime P, Phipps R, Thanavala Y J Immunol. 2014; 192(11):5226-35.

PMID: 24752444 PMC: 4066560. DOI: 10.4049/jimmunol.1302584.

References

Peters S, Kunselman S, Icitovic N, Moore W, Pascual R, Ameredes B . Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010; 363(18):1715-26. PMC: 3011177. DOI: 10.1056/NEJMoa1008770. View

Yawn B . Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medscape J Med. 2009; 11(1):20. PMC: 2654706. View

Fabbri L, Calverley P, Izquierdo-Alonso J, Bundschuh D, Brose M, Martinez F . Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet. 2009; 374(9691):695-703. DOI: 10.1016/S0140-6736(09)61252-6. View

Stephens M, Yew K . Diagnosis of chronic obstructive pulmonary disease. Am Fam Physician. 2008; 78(1):87-92. View

Ries A, Bauldoff G, Carlin B, Casaburi R, Emery C, Mahler D . Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007; 131(5 Suppl):4S-42S. DOI: 10.1378/chest.06-2418. View

. Cigarette smoking among adults--United States, 2006. MMWR Morb Mortal Wkly Rep. 2007; 56(44):1157-61. View

Beeh K, Kornmann O, Beier J, Ksoll M, Buhl R . Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med. 2004; 98(7):591-7. DOI: 10.1016/j.rmed.2004.01.004. View

Sin D, McAlister F, Paul Man S, Anthonisen N . Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003; 290(17):2301-12. DOI: 10.1001/jama.290.17.2301. View

Pleis J, Lucas J, Ward B . Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 10. 2010; (242):1-157. View

10.

Mapp C, Boschetto P, Maestrelli P, Fabbri L . Occupational asthma. Am J Respir Crit Care Med. 2005; 172(3):280-305. DOI: 10.1164/rccm.200311-1575SO. View

11.

van der Molen T, Ostrem A, Stallberg B, Ostergaard M, Singh R . International Primary Care Respiratory Group (IPCRG) Guidelines: management of asthma. Prim Care Respir J. 2006; 15(1):35-47. PMC: 6730678. DOI: 10.1016/j.pcrj.2005.11.001. View

12.

Dahlen S, Malmstrom K, Nizankowska E, Dahlen B, Kuna P, Kowalski M . Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2002; 165(1):9-14. DOI: 10.1164/ajrccm.165.1.2010080. View

13.

Niska R, Bhuiya F, Xu J . National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report. 2010; (26):1-31. View

14.

Garcia-Aymerich J, Hernandez C, Alonso A, Casas A, Rodriguez-Roisin R, Anto J . Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med. 2007; 101(7):1462-9. DOI: 10.1016/j.rmed.2007.01.012. View

15.

Sandstrom T . Omalizumab in the management of patients with allergic (IgE-mediated) asthma. J Asthma Allergy. 2011; 2:49-62. PMC: 3048609. DOI: 10.2147/jaa.s3116. View

16.

Tokuda Y, Miyagi S . Physical diagnosis of chronic obstructive pulmonary disease. Intern Med. 2007; 46(23):1885-91. DOI: 10.2169/internalmedicine.46.0455. View

17.

Mannino D, Braman S . The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007; 4(7):502-6. DOI: 10.1513/pats.200701-001FM. View

18.

Soriano J, Davis K, Coleman B, Visick G, Mannino D, Pride N . The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003; 124(2):474-81. DOI: 10.1378/chest.124.2.474. View

19.

Mannino D, Homa D, Akinbami L, Ford E, Redd S . Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ. 2002; 51(6):1-16. View

20.

Tarlo S, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D . Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008; 134(3 Suppl):1S-41S. DOI: 10.1378/chest.08-0201. View